Spire Wealth Management Caladrius Biosciences, Inc. Transaction History

Spire Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$0.41 - $0.74 $445 - $804	1,087 New	1,087 $1,000
Q1 2022 Apr 18, 2022	SELL	$0.63 - $1.03 $1,435 - $2,346	-2,278 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$0.83 - $1.22 $1,890 - $2,779	2,278 New	2,278 $2,000
Q2 2021 Jul 26, 2021	SELL	$1.4 - $1.9 $18,163 - $24,650	-12,974 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$1.44 - $2.89 $18,682 - $37,494	12,974 New	12,974 $25,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.